Synthesis of 1-[11C]Methylpiperidin-4-yl propionate (11C]PMP) for in vivo measurements of acetylcholinesterase activity

Nuclear Medicine and Biology

Volumn 25, Issue 8, 1998, Pages 751-754

  Snyder, Scott E ^a   Tluczek, Louis ^a   Jewett, Douglas M ^a   Nguyen, Thinh B ^a   Kuhl, David E ^a   Kilbourn, Michael R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acetylcholinesterase; Carbon 11; Computed tomography emission

Indexed keywords

ACETYLCHOLINESTERASE; CARBON 11; PROPIONIC ACID DERIVATIVE; CARBON; DIAGNOSTIC AGENT; MESYLIC ACID DERIVATIVE; N METHYLPIPERIDIN 4 YL PROPIONATE; N,N DIMETHYLFORMAMIDE; N-METHYLPIPERIDIN-4-YL PROPIONATE; RADIOPHARMACEUTICAL AGENT; TRIFLUOROMETHANESULFONIC ACID METHYL ESTER;

ACETYLCHOLINE BRAIN LEVEL; BRAIN METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; ARTICLE; BRAIN; CATALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENZYMOLOGY; HUMAN; HYDROGENATION; ISOLATION AND PURIFICATION; ISOTOPE LABELING; METABOLISM; SCINTISCANNING; SYNTHESIS;

ACETYLCHOLINESTERASE; BRAIN; CARBON RADIOISOTOPES; CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIMETHYLFORMAMIDE; HUMANS; HYDROGENATION; ISOTOPE LABELING; MESYLATES; PROPIONATES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032194844     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00045-6     Document Type: Conference Paper

References (12)

1. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., Davis K.L. Neurochemical correlates of dementia severity in Alzheimer's disease Relative importance of cholinergic deficits . J. Neurochem. 64:1995;740-760.
2. Bormans G., Sherman P., Snyder S.E., Kilbourn M.R. Synthesis of carbon-11 and fluorine-18 labeled 1-methyl-4-piperidyl 4-fluorobenzoate and their biodistribution in mice. Nucl. Med. Biol. 23:1996;513-517.
3. Frey K.A., Koeppe R.A., Kilbourn M.R., Snyder S.E., Kuhl D.E. PET quantification of cortical acetylcholinesterase inhibition in monkey and human. J. Nucl. Med. 38:1997;146P.
4. Greene T. W. and Wuts P. G. M. (1991) Protective Groups in Organic Synthesis, 2nd edn, pp. 335-340. John Wiley & Sons, New York.
5. Hucho F., Jarv J., Wiese C. Substrate-binding sites in acetylcholinesterase. Trends Pharmacol. Sci. 12:1991;422-426.
6. Irie T., Fukushi K., Akimoto Y., Tamagami H., Nozaki T. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. Nucl. Med. Biol. 21:1994;801-808.
7. Iyo M., Namba H., Fukushi K., Shinotoh H., Hagatsuka S., Suhara T., Sudo Y., Suzuki K., Irie T. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease. Lancet. 349:1997;1805-1809.
8. 11C]methyl triflate. Appl. Radiat. Isot. 43:1992;1383-1385.
9. 11C]PMP). Synapse. 22:1996;123-131.
10. Koeppe R.A., Frey K.A., Snyder S.E., Kilbourn M.R., Kuhl D.E. Kinetic analysis alternatives for assessing AChE activity with N-[C-11]methylpiperidinyl propionate (PMP) To constrain or not to constrain? J. Nucl. Med. 38:1997;198P.
11. Kuhl D.E., Koeppe R.A., Snyder S.E., Minoshima S., Frey K.A., Kilbourn M.R. Mapping acetylcholinesterase in human brain using PET and N-[C-11]methylpiperidinyl propionate (PMP). J. Nucl. Med. 37:1996;21P.
12. Waters J.A. Aromatic esters of nonquaternary carbon-4 piperidinols as analgesics. J. Med. Chem. 21:1978;628-633.